Page last updated: 2024-09-02

indolo(3,2-b)carbazole and go 6976

indolo(3,2-b)carbazole has been researched along with go 6976 in 1 studies

Compound Research Comparison

Studies
(indolo(3,2-b)carbazole)
Trials
(indolo(3,2-b)carbazole)
Recent Studies (post-2010)
(indolo(3,2-b)carbazole)
Studies
(go 6976)
Trials
(go 6976)
Recent Studies (post-2010) (go 6976)
30075041133

Protein Interaction Comparison

ProteinTaxonomyindolo(3,2-b)carbazole (IC50)go 6976 (IC50)
Protein kinase C gamma typeHomo sapiens (human)0.002
Protein kinase C beta typeHomo sapiens (human)0.0041
Protein kinase C alpha typeHomo sapiens (human)0.0027
Protein kinase C delta typeHomo sapiens (human)0.446
Serine/threonine-protein kinase D1Homo sapiens (human)0.0445

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freitag, M; Kupfer, R; Marschall, M; Stamminger, T; Stein-Gerlach, M; van den Bogaard, M1

Other Studies

1 other study(ies) available for indolo(3,2-b)carbazole and go 6976

ArticleYear
Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97.
    The Journal of general virology, 2001, Volume: 82, Issue:Pt 6

    Topics: Antiviral Agents; Carbazoles; Cell Line; Clone Cells; Cytomegalovirus; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enzyme Inhibitors; Ganciclovir; Humans; Indoles; Mutation; Mutation, Missense; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Protein Kinases; Virus Replication

2001